John McBride - Feb 1, 2023 Form 4 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role
Director
Signature
/s/ John McBride
Stock symbol
ELDN
Transactions as of
Feb 1, 2023
Transactions value $
$0
Form type
4
Date filed
2/2/2023, 05:08 PM
Previous filing
Feb 2, 2022
Next filing
May 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELDN Stock Option (right to buy) Award $0 +20K $0.00 20K Feb 1, 2023 Common Stock 20K $3.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase up to 20,000 shares of Common Stock, which option vests with respect to 100% of the total number of shares on 2/1/2024.